Sidney Stephen
Kaiser Permanente Northern California Division of Research, 2000 Broadway, Oakland, CA, 94612, USA.
Curr Diab Rep. 2016 Nov;16(11):117. doi: 10.1007/s11892-016-0795-6.
Marijuana is used by millions of people, with use likely to increase in the USA because of the trend towards increased decriminalization and legalization. Obesity and diabetes mellitus (DM) rates have increased dramatically in the USA over the past 30 years, with a recent estimate of 29 million individuals with DM. Because there is a plausible link between marijuana use and diabetes due to the known effects of cannabinoids on adipose tissue and glucose/insulin metabolism, it is important to study and understand how marijuana use is related to obesity and diabetes. This paper provides background on the human endocannabinoid system and studies of the association of marijuana use with body mass index/obesity, metabolic syndrome, prediabetes, and diabetes. The studies to date have shown that marijuana use is associated with either lower odds or no difference in the odds of diabetes than non-use.
数以百万计的人使用大麻,在美国,由于大麻非刑罪化和合法化趋势加剧,大麻的使用量可能会增加。在过去30年里,美国的肥胖症和糖尿病(DM)发病率急剧上升,最近估计有2900万糖尿病患者。由于大麻素对脂肪组织和葡萄糖/胰岛素代谢有已知影响,大麻使用与糖尿病之间存在合理联系,因此研究和了解大麻使用与肥胖症和糖尿病之间的关系非常重要。本文提供了关于人类内源性大麻素系统的背景知识,以及大麻使用与体重指数/肥胖症、代谢综合征、糖尿病前期和糖尿病之间关联的研究。迄今为止的研究表明,与不使用大麻相比,使用大麻与患糖尿病的几率较低或无差异有关。